Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice

Neuroscience Letters

Volumn 261, Issue 3, 1999, Pages 147-150

  Mogil, Jeffrey S ^a,b   Nessim, Leslie A ^a   Wilson, Sonya G ^b  

^a 603 E Daniel Street ^*  (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Anti opioid; Genetics; Mice; Nociception; Pain; Strain differences; Stress induced analgesia

Indexed keywords

NOCICEPTIN; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; CHROMOSOME 2; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; MALE; MOLECULAR CLONING; MOUSE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE;

EID: 0033582749     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00012-9     Document Type: Article

References (22)

1. Belknap J.K., Crabbe J.C. Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Ann. N.Y. Acad. Sci. 654:1992;311-323.
2. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
3. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand, nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
4. King M., Chang A., Pasternak G.W. Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem. Pharmacol. 55:1998;1537-1540.
5. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice: some methodological refinements. J. Pharmacol. Meth. 16:1986;355-357.
6. 1 receptor. Nature. 377:1995;532-535.
7. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
8. Mogil J.S., Grisel J.E., Zhang G., Belknap J.K., Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
9. Mogil J.S., Sternberg W.F., Marek P., Sadowski B., Belknap J.K., Liebeskind J.C. The genetics of pain and pain inhibition. Proc. Natl. Acad. Sci. USA. 93:1996;3048-3055.
10. Mogil, J.S., Wilson, S.G., Bon, K., Lee, S.E., Chung, K., Raber, P., Pieper, J.O., Hain, H.S., Belknap, J.K., Hubert, L., Elmer, G.I., Chung, J.M. and Devor, M., Heritability of nociception. I. Responses of eleven inbred mouse strains on twelve measures of nociception, Pain (1999) in press.
11. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16:1997;1858-1864.
12. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higashioka M., Takeshima H. Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem. 273:1998;18047-18051.
13. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
14. Rossi G.C., Leventhal L., Bolan E.A., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:1997;858-865.
15. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8.
16. Rossi G.C., Perlmutter M., Leventhal L., Talatti A., Pasternak G.W. Orphanin FQ/nociceptin analgesia in the rat. Brain Res. 792:1998;327-330.
17. Shimohigashi Y., Hatano R., Fujita T., Nakashima R., Nose T., Sujaku T., Saigo A., Shinjo K., Nagahisa A. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide. J. Biol. Chem. 271:1996;23642-23645.
18. Suaudeau C., Florin S., Meunier J.-C., Costentin J. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam. Clin. Pharmacol. 12:1998;420-425.
19. Tian J.-H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of rat. Br. J. Pharmacol. 120:1996;676-680.
20. Vanderah, T.W., Raffa, R.B., Lashbrook, J., Burritt, A., Hruby, V. and Porreca, F., Orphanin-FQ/nociceptin: lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats, Eur. J. Pain, 2 (1998) 267-280.
21. Zaki P.A., Evans C.J. ORL-1: an awkward child of the opioid receptor family. Neuroscientist. 4:1998;172-184.
22. Zhu C.-B., Xu S.-F., Cao X.-D., Wu G.-C. Antagonistic action of orphanin FQ on acupuncture analgesia in rat brain. Acupunct. Electro-Ther. Res. Int. J. 21:1996;199-205.